Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt

Toshio Kubota, T. Yano, K. Fujisaki, Y. Itoh, R. Oishi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Fibric acid derivatives have a potent and effective lipid-lowering action, however, the use of these compounds is sometimes limited due to the occurrence of hepatic injury. In the present study, we characterized cell injury induced by fenofibrate in cultured human hepatocytes. Fenofibrate caused a loss of cell viability and nuclear damage as assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling or by DNA electrophoresis, in which caspase activation is involved. The cell injury was accompanied by the shrinkage and the translocation of phosphatidyl serine from inner membrane to the outer membrane as determined by annexin V stain. The mRNA expression for bcl-2 was reduced by fenofibrate. An immunofluorescent stain with antiserum raised against phosphorylated Akt revealed that fenofibrate inhibited insulin-stimulated phosphorylation of Akt. Like fenofibrate, several compounds that inhibit the phosphorylation of Akt, including wortmannin, SH-6 and a high concentration (100 μ M) of SB203580, reduced the viability of cultured human hepatocytes. Both nuclear damage and cell injury induced by fenofibrate were reversed by insulin in a concentration-dependent manner. In contrast, bezafibrate or 8(S)-hydroxyeicosatetraenoic acid had no hepatotoxic action. These findings suggest that fenofibrate causes caspase-dependent apoptosis in human hepatocytes by inhibiting phosphorylation of Akt, in which PPARα is not involved.

Original languageEnglish
Pages (from-to)349-358
Number of pages10
JournalApoptosis
Volume10
Issue number2
DOIs
Publication statusPublished - Mar 1 2005

Fingerprint

Fenofibrate
Phosphorylation
Hepatocytes
Wounds and Injuries
Caspases
Coloring Agents
Bezafibrate
Insulin
Membranes
Fibric Acids
Hydroxyeicosatetraenoic Acids
Peroxisome Proliferator-Activated Receptors
DNA Nucleotidylexotransferase
Annexin A5
Phosphatidylserines
Electrophoresis
Labeling
Immune Sera
Cell Survival
Chemical activation

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Cancer Research

Cite this

Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt. / Kubota, Toshio; Yano, T.; Fujisaki, K.; Itoh, Y.; Oishi, R.

In: Apoptosis, Vol. 10, No. 2, 01.03.2005, p. 349-358.

Research output: Contribution to journalArticle

Kubota, Toshio ; Yano, T. ; Fujisaki, K. ; Itoh, Y. ; Oishi, R. / Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt. In: Apoptosis. 2005 ; Vol. 10, No. 2. pp. 349-358.
@article{6d89da961629437499f98360bc929c89,
title = "Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt",
abstract = "Fibric acid derivatives have a potent and effective lipid-lowering action, however, the use of these compounds is sometimes limited due to the occurrence of hepatic injury. In the present study, we characterized cell injury induced by fenofibrate in cultured human hepatocytes. Fenofibrate caused a loss of cell viability and nuclear damage as assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling or by DNA electrophoresis, in which caspase activation is involved. The cell injury was accompanied by the shrinkage and the translocation of phosphatidyl serine from inner membrane to the outer membrane as determined by annexin V stain. The mRNA expression for bcl-2 was reduced by fenofibrate. An immunofluorescent stain with antiserum raised against phosphorylated Akt revealed that fenofibrate inhibited insulin-stimulated phosphorylation of Akt. Like fenofibrate, several compounds that inhibit the phosphorylation of Akt, including wortmannin, SH-6 and a high concentration (100 μ M) of SB203580, reduced the viability of cultured human hepatocytes. Both nuclear damage and cell injury induced by fenofibrate were reversed by insulin in a concentration-dependent manner. In contrast, bezafibrate or 8(S)-hydroxyeicosatetraenoic acid had no hepatotoxic action. These findings suggest that fenofibrate causes caspase-dependent apoptosis in human hepatocytes by inhibiting phosphorylation of Akt, in which PPARα is not involved.",
author = "Toshio Kubota and T. Yano and K. Fujisaki and Y. Itoh and R. Oishi",
year = "2005",
month = "3",
day = "1",
doi = "10.1007/s10495-005-0809-3",
language = "English",
volume = "10",
pages = "349--358",
journal = "Apoptosis : an international journal on programmed cell death",
issn = "1360-8185",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt

AU - Kubota, Toshio

AU - Yano, T.

AU - Fujisaki, K.

AU - Itoh, Y.

AU - Oishi, R.

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Fibric acid derivatives have a potent and effective lipid-lowering action, however, the use of these compounds is sometimes limited due to the occurrence of hepatic injury. In the present study, we characterized cell injury induced by fenofibrate in cultured human hepatocytes. Fenofibrate caused a loss of cell viability and nuclear damage as assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling or by DNA electrophoresis, in which caspase activation is involved. The cell injury was accompanied by the shrinkage and the translocation of phosphatidyl serine from inner membrane to the outer membrane as determined by annexin V stain. The mRNA expression for bcl-2 was reduced by fenofibrate. An immunofluorescent stain with antiserum raised against phosphorylated Akt revealed that fenofibrate inhibited insulin-stimulated phosphorylation of Akt. Like fenofibrate, several compounds that inhibit the phosphorylation of Akt, including wortmannin, SH-6 and a high concentration (100 μ M) of SB203580, reduced the viability of cultured human hepatocytes. Both nuclear damage and cell injury induced by fenofibrate were reversed by insulin in a concentration-dependent manner. In contrast, bezafibrate or 8(S)-hydroxyeicosatetraenoic acid had no hepatotoxic action. These findings suggest that fenofibrate causes caspase-dependent apoptosis in human hepatocytes by inhibiting phosphorylation of Akt, in which PPARα is not involved.

AB - Fibric acid derivatives have a potent and effective lipid-lowering action, however, the use of these compounds is sometimes limited due to the occurrence of hepatic injury. In the present study, we characterized cell injury induced by fenofibrate in cultured human hepatocytes. Fenofibrate caused a loss of cell viability and nuclear damage as assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling or by DNA electrophoresis, in which caspase activation is involved. The cell injury was accompanied by the shrinkage and the translocation of phosphatidyl serine from inner membrane to the outer membrane as determined by annexin V stain. The mRNA expression for bcl-2 was reduced by fenofibrate. An immunofluorescent stain with antiserum raised against phosphorylated Akt revealed that fenofibrate inhibited insulin-stimulated phosphorylation of Akt. Like fenofibrate, several compounds that inhibit the phosphorylation of Akt, including wortmannin, SH-6 and a high concentration (100 μ M) of SB203580, reduced the viability of cultured human hepatocytes. Both nuclear damage and cell injury induced by fenofibrate were reversed by insulin in a concentration-dependent manner. In contrast, bezafibrate or 8(S)-hydroxyeicosatetraenoic acid had no hepatotoxic action. These findings suggest that fenofibrate causes caspase-dependent apoptosis in human hepatocytes by inhibiting phosphorylation of Akt, in which PPARα is not involved.

UR - http://www.scopus.com/inward/record.url?scp=18044373207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044373207&partnerID=8YFLogxK

U2 - 10.1007/s10495-005-0809-3

DO - 10.1007/s10495-005-0809-3

M3 - Article

C2 - 15843896

AN - SCOPUS:18044373207

VL - 10

SP - 349

EP - 358

JO - Apoptosis : an international journal on programmed cell death

JF - Apoptosis : an international journal on programmed cell death

SN - 1360-8185

IS - 2

ER -